HERV-E TCR-transduced autologous T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HERV-E TCR-transduced autologous T cells, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma [Phase 1]